Dhampur Bio Oragnics Lid (Dbol) (NSE: DBOL, BSE: 543593) is a New Delhi, Delhi-based company in the Sweeteners industry. With a market capitalisation of ₹922 Cr, it ranks #1,633 by market cap among the 6,197 Indian listed companies on FinBizNet, and #13 of 42 in Sweeteners. At ₹146.19 (as of 16 Nov 2026), the share price is 3.7% below its 52-week high of ₹151.80 and 111.9% above its 52-week low of ₹69.00. The share price is up 92.9% over one year and up 24.2% over three months.
| Current Price | ₹146.19 |
|---|---|
| Market Cap | ₹922 Cr |
| NSE Symbol | DBOL |
| BSE Code | 543593 |
| Sector | Consumer Staples > Food, Beverage and Tobacco > Food Products |
| Sub-Industry | Packaged Foods and Meats > Sweeteners |
| P/E Ratio | 38.2 |
| Return on Equity | 2.47% |
| Return on Assets | 2.08% |
| 52-Week Range | ₹69.00 – ₹151.80 |
| 1-Year Price Change | +92.9% |
| 3-Month Price Change | +24.2% |
| Beta (1Y) | 0.31 |
| Dividend Yield | 1.03% |
| Headquarters | New Delhi, Delhi |
| Website | www.dhampur.com |
| Revenue | ₹1,026 Cr |
|---|---|
| Net Profit | ₹29 Cr |
| Net Margin | 2.8% |
| EPS (Basic) | ₹4.43 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Dhampur Bio Oragnics Lid (Dbol) reported revenue of ₹1,026 Cr in Q2 FY27, up 24.4% from ₹825 Cr in Q2 FY26 and up 11.7% from ₹919 Cr in Q1 FY27. It posted a net profit of ₹29 Cr for the quarter, against a net loss of ₹16 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹703 Cr (Q4 FY25) to ₹1,026 Cr (Q2 FY27). The company reported a net loss in 2 of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹1,026 Cr | ₹29 Cr | 2.8% |
| Q1 FY27 | ₹919 Cr | ₹37 Cr | 4.0% |
| Q4 FY26 | ₹774 Cr | ₹46 Cr | 6.0% |
| Q3 FY26 | ₹751 Cr | ₹17 Cr | 2.2% |
| Q2 FY26 | ₹825 Cr | −₹16 Cr | −1.9% |
| Q1 FY26 | ₹784 Cr | −₹22 Cr | −2.8% |
| Q4 FY25 | ₹703 Cr | ₹45 Cr | 6.4% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 51.00% of Dhampur Bio Oragnics Lid (Dbol)'s shares as of Sept 2026, against 50.65% in Sept 2025 (+0.35 percentage points). Delivery averaged 53.5% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Dhampur Bio Organics Limited, an integrated sugarcane processing company, engages in the manufacture and sale of refined, sulphitation, raw sugar, sugar, biomass-based renewable power, biofuels, potable liquor, chemicals, and allied products in India. The company operates through three segments: Sugar, Bio Fuels & Spirits, and Country Liquor. It also offers alcoholic beverages with 25% and 36% alcohol content; and ENA, a food-grade alcohol, as well as bagasse and organic fertilizer. In addition, the company manufactures and sells SDS, ethanol, sanitizer, etc., as well as engages in the co-generation and sale of power. The company also exports its products. Dhampur Bio Organics Limited was incorporated in 2020 and is based in New Delhi, India.
1. Sugar-This segment engages in the manufacture and sale of sugar and its byproducts; and co-generation and sale of power. 2. Bio Fuels & Spirits-This segment engages in the manufacture and sale of SDS, ENA, ethanol, country liquor, sanitizers, etc. 3. Country Liquor-0 4. Adjustments / Elimination-0
1. Sugar-58.8% 2. Bio Fuels & Spirits-12.8% 3. Country Liquor-36.3%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Balrampur Chini Mills Ltd. | ₹13,716 Cr | 35 | 9.54% | ₹1,876 Cr | +51.4% |
| Piccadily Agro Inds Limited | ₹5,832 Cr | 41.5 | 17.37% | ₹278 Cr | -21.1% |
| Triveni Engineering & Industries | ₹5,427 Cr | 20.4 | 8.26% | ₹2,049 Cr | -30.2% |
| Bajaj Hindusthan Sugar Limited | ₹4,377 Cr | 21.2 | 3.14% | ₹968 Cr | -13.2% |
| Shree Renuka Sugars Ltd. | ₹4,012 Cr | n/m | 36.42% | ₹1,905 Cr | -33.5% |
| Bannari Amman Sugars Ltd. | ₹3,954 Cr | 26.9 | 8.01% | ₹340 Cr | -13.2% |
| Dalmia Bharat Sugar And Industries Ltd | ₹3,905 Cr | 16.5 | 7.29% | ₹1,061 Cr | +48.6% |
| Amir Chand Jagdish Kumar (Exports) Limited | ₹2,548 Cr | 19.3 | 11.18% | ₹694 Cr | — |
| Dhampur Bio Oragnics Lid (Dbol) | ₹922 Cr | 38.2 | 2.47% | ₹1,026 Cr | +92.9% |
Listed by market capitalisation. Ratios are shown for context only.
Dhampur Bio Oragnics Lid (Dbol) is trading at ₹146.19, with a market capitalisation of ₹922 Cr.
Dhampur Bio Oragnics Lid (Dbol) operates in the Consumer Staples > Food, Beverage and Tobacco > Food Products space (Packaged Foods and Meats > Sweeteners).
Dhampur Bio Oragnics Lid (Dbol) has a P/E of 38.2 and a return on equity of 2.47%.
Dhampur Bio Oragnics Lid (Dbol) is listed on the NSE under the symbol DBOL and on the BSE under the scrip code 543593.
Dhampur Bio Oragnics Lid (Dbol)'s share price is up 92.9% over one year and up 24.2% over three months. Its 52-week range is ₹69.00 to ₹151.80.
In Q2 FY27, Dhampur Bio Oragnics Lid (Dbol) reported revenue of ₹1,026 Cr and net profit of ₹29 Cr, with basic EPS of ₹4.43 (consolidated, parsed from the company's exchange filing).
Dhampur Bio Oragnics Lid (Dbol) reported revenue of ₹1,026 Cr in Q2 FY27, up 24.4% from ₹825 Cr in Q2 FY26 and up 11.7% from ₹919 Cr in Q1 FY27.
Promoters held 51.00% of Dhampur Bio Oragnics Lid (Dbol)'s shares as of Sept 2026, against 50.65% in Sept 2025 (+0.35 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.